U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
4287142871JC Virus Reactivation in Multiple SclerosisActive, not recruitingNo Results AvailableProgressive Multifocal Leukoencephalopathy|Multiple Sclerosishttps://ClinicalTrials.gov/show/NCT02004444
4287242872Peri-operative Psychology and Post-operative Pain StudyRecruitingNo Results AvailableSurgery|Pain|Anxiety|Depressionhttps://ClinicalTrials.gov/show/NCT02004431
4287342873A Study for Patients With Prostate Cancer to See Whether Delivering an Extra Dose of Radiation to Parts of the Body With More Cancer is Better Than Standard Treatment in Which the Same Dose of Radiation is Given Throughout the Prostate GlandRecruitingNo Results AvailableProstatic NeoplasmsRadiation: 11C-Cholinehttps://ClinicalTrials.gov/show/NCT02004418
4287442874Heart Rate Variability in Fibromyalgia - Effects of Strengthening ExercisesCompletedNo Results AvailableFibromyalgiaOther: strengthening exercise|Other: flexibility exercisehttps://ClinicalTrials.gov/show/NCT02004405
4287542875Study of the Safety and Clinical Effects of 2 Doses of EVP-6124 in Subjects With Alzheimer's Disease Who Complete Study EVP-6124-024 or EVP-6124-025SuspendedNo Results AvailableAlzheimer's Disease|DementiaDrug: EVP-6124https://ClinicalTrials.gov/show/NCT02004392
4287642876Register of Telaprevir and Boceprevir in Routine Clinical PracticeCompletedNo Results AvailableHepatitis Chttps://ClinicalTrials.gov/show/NCT02004379
4287742877Linagliptin Inpatient TrialRecruitingNo Results AvailableType 2 DiabetesDrug: Linagliptin|Drug: Basal Bolus|Drug: Linagliptin|Drug: Linagliptin + 50% Glargine dose on discharge|Drug: Linagliptin + 80% Glarginehttps://ClinicalTrials.gov/show/NCT02004366
4287842878Observation of Benefits for Patients Implanted With a Hearing Implant of the Company CochlearRecruitingNo Results AvailableHearing LossDevice: Cochlear® Hearing Implantshttps://ClinicalTrials.gov/show/NCT02004353
4287942879Transcutaneous Auricular Vagus Nerve Stimulation for Pediatric EpilepsyRecruitingNo Results AvailableEpilepsyDevice: ear vagus nerve stimulatorhttps://ClinicalTrials.gov/show/NCT02004340
4288042880The Phase I Clinical Study to Evaluate the Pharmacokinetics of Dw1029M in Healthy Male VolunteerCompletedNo Results AvailableDiabetic Kidney DiseaseDrug: DW1029M300mg|Drug: DW1029M600mg|Drug: DW1029M1200mghttps://ClinicalTrials.gov/show/NCT02004327
4288142881Chloroquine as a Modulator of T Cell Immune ActivationCompletedNo Results AvailableHIVDrug: Chloroquinehttps://ClinicalTrials.gov/show/NCT02004314
4288242882A Study to Investigate Delayed-release TabletsCompletedNo Results AvailablePainDrug: Radiolabelled T4 Tablet|Drug: Radiolabelled T6 Tablethttps://ClinicalTrials.gov/show/NCT02004301
4288342883The Role of Lactobacillus Reuteri in Children and Adolescents With Anorexia NervosaRecruitingNo Results AvailableAnorexia Nervosa|ConstipationDietary Supplement: Lactobacillus reuteri Protectis DSM17938https://ClinicalTrials.gov/show/NCT02004288
4288442884Pomalidomide and Dexamethasone With or Without Ixazomib in Treating Patients With Refractory Multiple MyelomaRecruitingNo Results AvailableMultiple Myeloma in RelapseDrug: pomalidomide|Drug: ixazomib|Drug: dexamethasonehttps://ClinicalTrials.gov/show/NCT02004275
4288542885Safety and Efficacy of Combination Listeria/GVAX Pancreas Vaccine in the Pancreatic Cancer SettingActive, not recruitingNo Results Available2nd-line, 3rd-line and Greater Metastatic Pancreatic CancerBiological: GVAX Pancreas Vaccine|Biological: CRS-207|Drug: gemcitabine, capecitabine, 5-FU, irinotecan or erlotinib|Drug: cyclophosphamidehttps://ClinicalTrials.gov/show/NCT02004262
4288642886[Trial of device that is not approved or cleared by the U.S. FDA]WithheldNo Results Availablehttps://ClinicalTrials.gov/show/NCT02004249
4288742887Transcranial Random Noise Stimulation (tRNS) Over Fronto-temporal Cortex Improves Verbal Fluency and Empathy in Autism ChildrenCompletedHas ResultsAutism|ASDDevice: tRNS Fronto-temporal cortex|Device: tRNS over fusiform temporal cortex|Device: tRNS with shamhttps://ClinicalTrials.gov/show/NCT02004236
4288842888Early Investigation of High Precision Radiotherapy Prior to Commencing Standard Radiotherapy for Prostate CancerRecruitingNo Results AvailableProstate CancerRadiation: Dose escalation using stereotactic boosthttps://ClinicalTrials.gov/show/NCT02004223
4288942889A Phase 3 Trial Comparing TACE and TARE in Unilobar Advanced Hepatocellular CarcinomaRecruitingNo Results AvailableHepatocellular CarcinomaProcedure: transarterial radioembolization (TARE)|Procedure: transarterial chemoembolization (TACE)https://ClinicalTrials.gov/show/NCT02004210
4289042890Quadruple and Phytomedicine-based Therapies in H. Pylori InfectionCompletedNo Results AvailableHelicobacter Pylori [H. Pylori] as the Cause of DiseasesDrug: Quadruple Allopathic therapy|Drug: Pylorex plushttps://ClinicalTrials.gov/show/NCT02004197
4289142891Pemetrexed in Advanced Non-Small-Cell Lung Cancer: at Progression vs Maintenance Therapy After Induction ChemotherapyRecruitingNo Results AvailableCarcinoma, Non-small-cell LungDrug: maintenance pemetrexed|Drug: pemetrexed at progressionhttps://ClinicalTrials.gov/show/NCT02004184
4289242892Electronic Cigarettes or Nicotine Inhaler for Smoking CessationTerminatedNo Results AvailableTobacco Use DisorderOther: electronic cigarette|Drug: nicotine inhalerhttps://ClinicalTrials.gov/show/NCT02004171
4289342893Positive Psychology to Improve Healthy Behaviors After an Acute Coronary SyndromeCompletedNo Results AvailableAcute Coronary SyndromeBehavioral: Positive psychology interventionhttps://ClinicalTrials.gov/show/NCT02004158
4289442894Trial of a Positive Psychology Intervention in Major Depressive DisorderEnrolling by invitationNo Results AvailableMajor Depressive DisorderBehavioral: Positive Psychology|Behavioral: Control Conditionhttps://ClinicalTrials.gov/show/NCT02004145
4289542895A Study of Axiron® in Healthy ParticipantsCompletedHas ResultsHealthy VolunteersDrug: Axironhttps://ClinicalTrials.gov/show/NCT02004132
4289642896Phase 2 Study of KHK4577CompletedNo Results AvailableAtopic DermatitisDrug: KHK4577https://ClinicalTrials.gov/show/NCT02004119
4289742897A Study of RO6895882 in Patients With Advanced and/or Metastatic Solid TumorsRecruitingNo Results AvailableNeoplasmsDrug: RO6895882|Drug: RO6895882|Drug: RO6895882https://ClinicalTrials.gov/show/NCT02004106
4289842898A Study to Evaluate the Effect of the Combination of Pertuzumab With Carboplatin-Based Standard Chemotherapy in Patients With Recurrent Ovarian CancerCompletedHas ResultsOvarian CancerDrug: pertuzumab|Drug: paclitaxel|Drug: gemcitabine|Drug: carboplatinhttps://ClinicalTrials.gov/show/NCT02004093
4289942899CREACTIVE - Collaborative REsearch on ACute Traumatic Brain Injury in intensiVe Care Medicine in EuropeRecruitingNo Results AvailableBrain Injuries, TraumaticOther: Intensive Care treatmenthttps://ClinicalTrials.gov/show/NCT02004080
4290042900Safety Study of the Use of Topical Cyclosporine in the Treatment of Dry Eye DiseaseActive, not recruitingNo Results AvailablePrimary Sjogren Syndrome|Secondary Sjogren Syndrome|Aqueous Deficient Dry Eye Disease|Evaporative Dry Eye DiseaseDrug: Restasis|Drug: Refresh Endurahttps://ClinicalTrials.gov/show/NCT02004067

* Görseller ve İçerik tekif hakkına sahip olabilir